CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-14 | Labrucherie Gil M SVP & Chief Financial Officer | Grant or award · Stock Option | +87,500 | 87,500 | ||
| 2016-07-14 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award | +26,000 | 32,735 | ||
| 2016-07-14 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-07-14 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2016-07-14 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award | +15,000 | 16,521 | ||
| 2016-07-14 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-07-14 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +12,500 | 12,500 | ||
| 2016-07-14 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award | +10,500 | 11,521 | ||
| 2016-07-14 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-07-14 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Stock Option | +8,750 | 8,750 | ||
| 2016-07-11 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +100,000 | $4.65 | $465K | 106,809 |
| 2016-07-11 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −100,000 | $15.09 | $1.5M | 6,809 |
| 2016-07-11 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −100,000 | 0 | ||
| 2016-07-01 | CHESS ROBERT Director | Exercise or conversion | +5,000 | $5.15 | $26K | 265,623 |
| 2016-07-01 | CHESS ROBERT Director | Sale | −5,000 | $14.10 | $71K | 260,623 |
| 2016-07-01 | CHESS ROBERT Director | Exercise or conversion · Stock Option | −5,000 | 5,000 | ||
| 2016-06-01 | Nicholson John SVP & Chief Operating Officer | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2016-06-01 | Labrucherie Gil M SVP & Chief Financial Officer | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2016-06-01 | CHESS ROBERT Director | Exercise or conversion | +5,000 | $5.15 | $26K | 265,623 |
| 2016-06-01 | CHESS ROBERT Director | Sale | −5,000 | $15.50 | $78K | 260,623 |
Page 51 of 55 · 1,088 trades